Literature DB >> 2794464

Enterobacter sakazakii infections in neonates associated with intrinsic contamination of a powdered infant formula.

B P Simmons1, M S Gelfand, M Haas, L Metts, J Ferguson.   

Abstract

We report an outbreak of Enterobacter sakazakii infection and colonization in neonates related to an infant formula contaminated during the manufacturing process. The outbreak occurred in a 20-bed neonatal intensive care unit during a six-week period in 1988, and involved a total of four infants. Three infants had sepsis and three had bloody diarrhea; all patients responded to intravenous antibiotics and recovered without complications. The E sakazakii isolated from the formula had the same plasmid and multilocus enzyme profile as those isolated from patients. This outbreak demonstrates the significance of commercially contaminated formulas and emphasizes the need to limit contamination and multiplication of bacteria in enteral formulas.

Entities:  

Mesh:

Year:  1989        PMID: 2794464     DOI: 10.1086/646060

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  41 in total

1.  Fluorogenic selective and differential medium for isolation of Enterobacter sakazakii.

Authors:  Se-Wook Oh; Dong-Hyun Kang
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

Review 2.  Neonatal congenital microvillus atrophy.

Authors:  N Pecache; S Patole; R Hagan; D Hill; A Charles; J M Papadimitriou
Journal:  Postgrad Med J       Date:  2004-02       Impact factor: 2.401

3.  Characterization of putative virulence genes on the related RepFIB plasmids harbored by Cronobacter spp.

Authors:  A A Franco; L Hu; C J Grim; G Gopinath; V Sathyamoorthy; K G Jarvis; C Lee; J Sadowski; J Kim; M H Kothary; B A McCardell; B D Tall
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

4.  Development and application of a novel peptide nucleic acid probe for the specific detection of Cronobacter genomospecies (Enterobacter sakazakii) in powdered infant formula.

Authors:  C Almeida; N F Azevedo; C Iversen; S Fanning; C W Keevil; M J Vieira
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

5.  Effectiveness of disinfectants in killing Enterobacter sakazakii in suspension, dried on the surface of stainless steel, and in a biofilm.

Authors:  Hoikyung Kim; Jee-Hoon Ryu; Larry R Beuchat
Journal:  Appl Environ Microbiol       Date:  2006-12-15       Impact factor: 4.792

6.  Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis.

Authors:  Catherine J Hunter; Vijay K Singamsetty; Nikunj K Chokshi; Patricia Boyle; Victoria Camerini; Anatoly V Grishin; Jeffrey S Upperman; Henri R Ford; Nemani V Prasadarao
Journal:  J Infect Dis       Date:  2008-08-15       Impact factor: 5.226

7.  Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis.

Authors:  Catherine J Hunter; Monica Williams; Mikael Petrosyan; Yigit Guner; Rahul Mittal; Dennis Mock; Jeffrey S Upperman; Henri R Ford; Nemani V Prasadarao
Journal:  Infect Immun       Date:  2008-12-15       Impact factor: 3.441

8.  Comparison of media for the isolation of Enterobacter sakazakii.

Authors:  Carol Iversen; Stephen J Forsythe
Journal:  Appl Environ Microbiol       Date:  2006-10-27       Impact factor: 4.792

Review 9.  Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis.

Authors:  Claudia N Emami; Mikael Petrosyan; Stefano Giuliani; Monica Williams; Catherine Hunter; Nemani V Prasadarao; Henri R Ford
Journal:  Surg Infect (Larchmt)       Date:  2009-10       Impact factor: 2.150

10.  Surveillance of stool samples for the presence of Enterobacter sakazakii among Korean people.

Authors:  Jung Beom Kim; Seung-Hak Cho; Yong Bae Park; Jung Bok Lee; Jong Chan Kim; Bok Kwon Lee; Hae Kyung Lee; Hiun Suk Chae
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.